KULR Announces Bitcoin Treasury Strategy
HOUSTON, Dec. 04, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leader […]
TSX News -
Hut 8 Announces New ATM and Stock Repurchase Programs
MIAMI, Dec. 04, 2024 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a […]
Global Ship Lease Announces Agreement to Acquire Four High-Reefer ECO Containerships on Multi-Year Charters, with 10-Year Financing Committed
Addition of 4x 2015/2016-built, immediately cash-generative post-panamax vessels, purchased from non-conventional seller at a 30+% discount to open-market charter-free values, […]
Trio Provides Operational Update on McCool Ranch
Company Details Plans to Increase Production and Cash Flow Bakersfield, CA, Dec. 04, 2024 (GLOBE NEWSWIRE) — Trio Petroleum Corp […]
Inuvo to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
LITTLE ROCK, Ark., Dec. 04, 2024 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of advertising technology, […]
TSX News -
Ascot Restarts Mine Development at Premier Northern Lights
VANCOUVER, British Columbia, Dec. 04, 2024 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) […]
TSX News -
Telesat and MDA Space Complete Key Milestone for Telesat Lightspeed Constellation
OTTAWA, Ontario and BRAMPTON, Ontario, Dec. 04, 2024 (GLOBE NEWSWIRE) — Telesat (NASDAQ and TSX: TSAT), one of the world’s largest […]
Teva präsentiert positive Wirksamkeits- und Sicherheitsdaten von AJOVY® (Fremanezumab) zur Vorbeugung episodischer Migräne bei Kindern und Jugendlichen aus der Phase-III-Studie SPACE
AJOVY®(Fremanezumab) reduzierte die monatlichen Migränetage (MMD) und monatlichen Kopfschmerztage (MHD) im Vergleich zu Placebo über einen Zeitraum von 12 Wochen […]
Teva présente des données positives sur l’efficacité et la sécurité d’emploi d’AJOVY® (frémanézumab) pour la prévention de la migraine épisodique chez les enfants et les adolescents dans le cadre de l’essai clinique de phase III SPACE
AJOVY®(frémanézumab) a permis de réduire de manière significative le nombre de jours de migraine mensuels (MMD, de l’anglais « monthly migraine […]
TSX News -
Altus Group Recognized as One of Greater Toronto’s Top Employers for 2025
TORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) — Altus Group Limited (“Altus”, “Altus Group” and the “Company”) (TSX: AIF), a leading […]
